Literature DB >> 35399184

Outcomes of Sarcopenia Treatment for Malignant Bone and Soft Tissue Tumors in Elderly Patients.

Yoshitaka Ban1, Hoshi Manabu1, Naoto Oebisu1, Akiyoshi Shimatani1, Naoki Takada1, Hiroaki Nakamura1.   

Abstract

Background/Aim: We determined the impact of sarcopenia on the treatment outcomes of malignant bone and soft tissue tumors in elderly patients. Patients and
Methods: We retrospectively reviewed 76 patients (age ≥65 years) who were treated for malignant bone and soft tissue tumors. Sarcopenia was assessed by measuring the cross-sectional area of the psoas muscles at the L3 vertebra from preoperative computed tomography images and categorized using the total psoas area/m 2 (TPA/m 2 ) ≤5.0 cm 2 /m 2 . The patients' clinical data were then evaluated.
Results: The operation time, length of hospital stay, and median overall survival were not different between the sarcopenia (n=41) and no-sarcopenia (n=35) groups. The local recurrence rate (p=0.01) and incidence of postoperative complications (p=0.02) significantly differed between both groups. The TPA/m 2  of both groups significantly decreased at the final follow-up.
Conclusion: Sarcopenia negatively influenced wound healing and local recurrence, and was significantly exacerbated postoperatively in all elderly patients. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Sarcopenia; local recurrence; malignant bone; postoperative complications; soft tissue tumor; wide resection

Year:  2022        PMID: 35399184      PMCID: PMC8962811          DOI: 10.21873/cdp.10094

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  14 in total

1.  New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.

Authors:  Kazuhiro Tanaka; Toshifumi Ozaki
Journal:  Jpn J Clin Oncol       Date:  2019-02-01       Impact factor: 3.019

2.  Sarcopenia: origins and clinical relevance.

Authors:  Irwin H Rosenberg
Journal:  Clin Geriatr Med       Date:  2011-06-08       Impact factor: 3.076

3.  Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis.

Authors:  Peter D Peng; Mark G van Vledder; Susan Tsai; Mechteld C de Jong; Martin Makary; Julie Ng; Barish H Edil; Christopher L Wolfgang; Richard D Schulick; Michael A Choti; Ihab Kamel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2011-03-29       Impact factor: 3.647

Review 4.  Sarcopenia associated with chemotherapy and targeted agents for cancer therapy.

Authors:  Mellar P Davis; Rajiv Panikkar
Journal:  Ann Palliat Med       Date:  2018-09-07

5.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.

Authors:  Hou-Qun Ying; Qi-Wen Deng; Bang-Shun He; Yu-Qin Pan; Feng Wang; Hui-Ling Sun; Jie Chen; Xian Liu; Shu-Kui Wang
Journal:  Med Oncol       Date:  2014-10-30       Impact factor: 3.064

6.  Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.

Authors:  M Trojani; G Contesso; J M Coindre; J Rouesse; N B Bui; A de Mascarel; J F Goussot; M David; F Bonichon; C Lagarde
Journal:  Int J Cancer       Date:  1984-01-15       Impact factor: 7.396

7.  The concept of curative margin in surgery for bone and soft tissue sarcoma.

Authors:  Noriyoshi Kawaguchi; Adel Refaat Ahmed; Seiichi Matsumoto; Jun Manabe; Yasushi Matsushita
Journal:  Clin Orthop Relat Res       Date:  2004-02       Impact factor: 4.176

Review 8.  The Complex Role of Neutrophils in Tumor Angiogenesis and Metastasis.

Authors:  Wei Liang; Napoleone Ferrara
Journal:  Cancer Immunol Res       Date:  2016-02       Impact factor: 11.151

9.  Impact of Preoperative Neutrophil to Lymphocyte Ratio and Postoperative Infectious Complications on Survival After Curative Gastrectomy for Gastric Cancer: A Single Institutional Cohort Study.

Authors:  Yasuhiko Mohri; Koji Tanaka; Yuji Toiyama; Masaki Ohi; Hiromi Yasuda; Yasuhiro Inoue; Masato Kusunoki
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 10.  Albert C. Broders, tumor grading, and the origin of the long road to personalized cancer care.

Authors:  James R Wright
Journal:  Cancer Med       Date:  2020-05-07       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.